NYSE:WSTLife Sciences
Assessing West Pharmaceutical Services (WST) Valuation After New US$1b Buyback And Earnings Update
West Pharmaceutical Services (WST) has paired a new share repurchase plan of up to US$1b with its regular US$0.22 quarterly dividend and recently reported 2025 results, giving investors several capital return angles to weigh.
See our latest analysis for West Pharmaceutical Services.
Those buyback and dividend decisions come after a mixed stretch for the stock, with a 1 day share price return of 2.08%, a 30 day share price return decline of 4.44%, and a year to date share price return decline...